Key Highlights:
- Hims & Hers Health (HIMS, Financial) announces a key leadership transition as COO Melissa Baird moves to an advisory role.
- Analyst consensus predicts a potential 72.20% upside in stock value within a year.
- Current "Hold" recommendation from brokerage firms with a GF Value estimate suggesting a 25.31% upside.
Hims & Hers Health (HIMS) recently disclosed a significant change in its leadership team. Chief Operating Officer Melissa Baird is set to transition into an advisory capacity over the coming months. While the official date of this transition awaits confirmation, Baird will continue in her role until her successor is completely onboarded. In response to the news, HIMS shares saw a slight decline of 0.08% during after-hours trading.
Analyzing Wall Street Predictions
Investors are keenly watching Hims & Hers Health Inc (HIMS, Financial) as 15 analysts have set forth their one-year price predictions. The average target price stands at $44.50, with predictions varying between a high of $85.00 and a low of $22.00. This average target price suggests a substantial 72.20% upside from the current valuation of $25.84. To dive deeper into these projections, visit the Hims & Hers Health Inc (HIMS) Forecast page.
Brokerage Recommendations
The consensus recommendation from 15 brokerage firms currently rates Hims & Hers Health Inc (HIMS, Financial) at an average of 2.7, indicating a "Hold" status. This rating is assessed on a scale of 1 to 5, where 1 represents a Strong Buy and 5 denotes a Sell signal. This neutral stance suggests cautious optimism about the company's potential.
Understanding GF Value Estimates
From the perspective of GuruFocus' proprietary metrics, the estimated GF Value for Hims & Hers Health Inc (HIMS, Financial) in the upcoming year is projected at $32.38. This implies a potential upside of 25.31% from the current stock price of $25.84. The GF Value is a sophisticated estimation of the fair trading value of the stock, derived from historical trading multiples alongside past and projected business performance. For a more comprehensive analysis, visit the Hims & Hers Health Inc (HIMS) Summary page.
